JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | (FY)Jun 30, 2020 | (Q6)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Inventory | -92.32%18.4M | 76.54%289M | 40.94%239.6M | -14.47%163.7M | -17.87%170M | -13.86%191.4M | -37.01%207M | -30.99%222.2M | -23.33%328.6M | -33.22%322M |
Accounts receivable | -2.31%9.16B | -0.69%9.53B | -34.05%9.38B | -35.81%9.59B | -6.23%14.22B | -5.35%14.94B | -6.45%15.16B | 4.47%15.79B | 15.83%16.21B | 5.37%15.11B |
Cash and equivalents | -23.20%14.79B | 13.44%20.07B | 43.14%19.26B | 51.54%17.69B | 24.51%13.45B | 6.25%11.67B | -18.28%10.8B | -12.13%10.99B | -12.20%13.22B | 71.87%12.5B |
Financial assets at fair value-current assets | ---- | ---- | ---- | -28.60%1.45B | 303.31%1.9B | 440.39%2.03B | 26.45%471.9M | -59.59%374.8M | 373,100.00%373.2M | --927.6M |
Derivative financial instruments-current assets | ---- | ---- | ---- | --32.2M | -96.58%27.4M | ---- | 114,442.86%801.8M | --635M | -87.50%700K | ---- |
Special items of current assets | 5.31%9.41B | -25.87%8.88B | -23.80%8.94B | -19.11%11.97B | -36.97%11.73B | -18.29%14.8B | 92.02%18.61B | 63.71%18.12B | --9.69B | --11.07B |
Total current assets | -11.72%33.38B | -5.23%38.76B | -8.90%37.81B | -6.27%40.9B | -9.90%41.5B | -5.39%43.64B | 15.66%46.06B | 15.50%46.13B | 35.07%39.83B | 80.69%39.93B |
Non-current assets | ||||||||||
Property, plant and equipment | -4.92%1.25B | -9.15%1.22B | 0.10%1.32B | 8.59%1.34B | 10.94%1.32B | 4.93%1.24B | -75.70%1.19B | -78.85%1.18B | -9.83%4.88B | 1.45%5.58B |
Investment property | -6.74%5.48B | 23.02%5.88B | 21.33%5.88B | 184.16%4.78B | 187.99%4.84B | 0.08%1.68B | -1.27%1.68B | -2.66%1.68B | -1.36%1.7B | -0.02%1.73B |
Associated company interest | -3.57%4.54B | -15.42%4.65B | -26.93%4.71B | -9.85%5.5B | 6.45%6.44B | -21.01%6.1B | -54.67%6.05B | -45.17%7.72B | -8.24%13.35B | -3.47%14.09B |
Interests in Joint Venture | -2.08%17.4B | -2.67%17.51B | 15.31%17.77B | 2.00%17.99B | 42.64%15.41B | 68.59%17.64B | -12.06%10.81B | -22.68%10.46B | -9.95%12.29B | -2.67%13.53B |
Financial assets at fair value-non-current assets | 11.17%59.75B | 469.60%60.49B | 386.26%53.74B | 0.35%10.62B | -11.95%11.05B | 2.56%10.58B | 47.87%12.55B | 41.85%10.32B | 97.40%8.49B | 124.42%7.27B |
Derivative financial instruments-non-current assets | 27.59%367.2M | 876.82%214.9M | 346.20%287.8M | -90.46%22M | -90.20%64.5M | -73.01%230.5M | -66.62%658.2M | --854M | 5,632.56%1.97B | ---- |
Intangible assets | -5.29%18.15B | 5.49%19B | 1.04%19.17B | -9.70%18.01B | -6.41%18.97B | -3.34%19.95B | 1.41%20.27B | -2.15%20.64B | 85.45%19.99B | 86.77%21.09B |
Other illiquid assets | ---- | ---- | ---- | -22.86%1.38B | -11.25%1.73B | -1.22%1.79B | 62.48%1.95B | -21.07%1.81B | -70.06%1.2B | 164.03%2.3B |
Special items of non-current assets | 73.71%2.16B | -70.04%2.67B | -83.58%1.24B | 19.38%8.89B | 6.59%7.57B | 11.29%7.45B | 12.10%7.11B | 11.01%6.69B | --6.34B | --6.03B |
Total non-current assets | 4.29%121.7B | 15.18%123.99B | 8.79%116.69B | -5.24%107.65B | 0.71%107.27B | 6.94%113.6B | -3.37%106.51B | -3.17%106.23B | 94.82%110.23B | 100.74%109.7B |
Total assets | 0.37%155.08B | 9.56%162.75B | 3.85%154.51B | -5.53%148.55B | -2.49%148.77B | 3.21%157.24B | 1.68%152.57B | 1.81%152.35B | 74.35%150.05B | 94.97%149.64B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | -10.36%9.7B | -9.82%10.82B | 4.00%10.82B | 11.63%12B | -8.21%10.4B | -13.96%10.75B | -9.15%11.33B | -2.80%12.49B | 15.31%12.48B | 13.46%12.85B |
Tax payable | -18.72%570.9M | -21.10%472.3M | 4.99%702.4M | -4.88%598.6M | 22.35%669M | 21.67%629.3M | 45.54%546.8M | 1.35%517.2M | -22.25%375.7M | -21.53%510.3M |
Bank loans and overdrafts | 25.63%29.9B | 498.55%34.42B | 351.75%23.8B | 426.51%5.75B | 148.64%5.27B | -58.97%1.09B | -47.87%2.12B | -20.90%2.66B | 69.10%4.06B | 23.08%3.37B |
Derivative financial instrument-current liabilities | 77.70%384.9M | 281.06%281.6M | 54,050.00%216.6M | --73.9M | --400K | ---- | ---- | --178M | 310.50%97.7M | ---- |
Investment contract liabilities - current liabilities | ---- | ---- | ---- | -15.44%8.63B | -19.73%8.65B | -2.45%10.2B | 18.96%10.77B | 10.15%10.46B | --9.05B | --9.5B |
Financial lease liabilities-current liabilities | -23.30%738.9M | 271.64%849.2M | 331.82%963.4M | 0.31%228.5M | -1.85%223.1M | -17.01%227.8M | -39.76%227.3M | -20.18%274.5M | --377.3M | --343.9M |
Special items of current liabilities | --366M | ---- | ---- | 21.38%34.68B | 30.28%31.73B | 27.94%28.57B | 19.14%24.36B | 15.76%22.33B | --20.45B | --19.29B |
Total current liabilities | 14.13%41.66B | -24.40%46.84B | -35.90%36.5B | 20.37%61.96B | 15.37%56.94B | 5.23%51.47B | 5.26%49.36B | 6.67%48.91B | 241.53%46.89B | 211.73%45.86B |
Net current assets | -730.60%-8.28B | 61.63%-8.08B | 108.50%1.31B | -168.83%-21.06B | -368.74%-15.44B | -180.90%-7.83B | 53.36%-3.29B | 52.92%-2.79B | -144.83%-7.06B | -180.13%-5.92B |
Total assets less current liabilities | -3.88%113.43B | 33.86%115.91B | 28.51%118.01B | -18.13%86.59B | -11.03%91.83B | 2.26%105.77B | 0.05%103.22B | -0.33%103.44B | 42.62%103.16B | 67.28%103.78B |
Non-current liabilities | ||||||||||
Long-term bank loan | ---- | ---- | ---- | -8.44%17.63B | -21.12%18.32B | -18.51%19.25B | -13.62%23.23B | -11.32%23.63B | 112.31%26.89B | 164.29%26.64B |
Financial lease liabilities-non-current liabilities | ---- | ---- | ---- | -17.48%809.9M | -16.47%901.6M | -17.47%981.4M | -31.47%1.08B | -27.09%1.19B | --1.58B | --1.63B |
Deferred tax liability | -10.34%1.27B | -15.45%1.38B | -20.97%1.41B | -13.90%1.63B | -7.18%1.79B | -3.82%1.89B | -15.77%1.93B | -20.06%1.97B | 1.05%2.29B | 4.52%2.46B |
Derivative financial instruments-non-current liabilities | ---- | ---- | ---- | 7.41%120.3M | 68.10%172.3M | 106.26%112M | -27.15%102.5M | --54.3M | 1,595.18%140.7M | ---- |
Investment contract liabilities-non-current liabilities | -5.33%4.19B | 2,097.09%4.22B | 2,218.97%4.42B | 2.23%192.2M | 5.53%190.8M | 8.17%188M | 7.49%180.8M | 7.55%173.8M | --168.2M | --161.6M |
Other non-current liabilities | ---- | ---- | ---- | -3.80%93.6M | -6.54%95.8M | -14.50%97.3M | -45.85%102.5M | -51.62%113.8M | 23.97%189.3M | 40.00%235.2M |
Special items of non-current liabilities | 14.52%64.62B | 288.56%62.3B | 242.60%56.43B | -12.91%16.03B | -9.22%16.47B | 12.42%18.41B | 25.52%18.14B | 22.00%16.38B | --14.45B | --13.42B |
Total non-current liabilities | 12.55%70.08B | 85.99%67.9B | 64.11%62.26B | -10.82%36.51B | -15.24%37.94B | -5.90%40.94B | -2.06%44.76B | -2.37%43.5B | 202.90%45.71B | 253.51%44.56B |
Total liabilities | 13.13%111.73B | 16.53%114.74B | 4.09%98.76B | 6.56%98.47B | 0.81%94.88B | -0.01%92.41B | 1.65%94.12B | 2.21%92.42B | 221.30%92.59B | 231.01%90.41B |
Total assets less total liabilities | -22.23%43.35B | -4.15%48.01B | 3.44%55.74B | -22.75%50.08B | -7.81%53.89B | 8.17%64.83B | 1.73%58.45B | 1.20%59.93B | 0.37%57.46B | 19.80%59.22B |
Total equity and non-current liabilities | -3.88%113.43B | 33.86%115.91B | 28.51%118.01B | -18.13%86.59B | -11.03%91.83B | 2.26%105.77B | 0.05%103.22B | -0.33%103.44B | 42.62%103.16B | 67.28%103.78B |
Equity | ||||||||||
Share capital | 2.22%4B | 0.04%3.91B | -0.02%3.91B | -0.02%3.91B | 0.00%3.91B | 0.00%3.91B | 0.00%3.91B | 0.00%3.91B | 0.00%3.91B | 0.22%3.91B |
Other equity instruments | -57.15%4.44B | -79.72%2.1B | -1.66%10.35B | -1.66%10.35B | 0.00%10.53B | 0.00%10.53B | 0.00%10.53B | 0.00%10.53B | 30.95%10.53B | --10.53B |
Reserve | -15.76%34.9B | 17.17%41.92B | 5.15%41.43B | -28.98%35.78B | -10.47%39.4B | 10.75%50.38B | 3.64%44B | 3.17%45.49B | -5.94%42.46B | -2.76%44.09B |
Special items of shareholders' rights and interests | 57.15%-4.44B | 79.72%-2.1B | 1.66%-10.35B | 1.66%-10.35B | 0.00%-10.53B | 0.00%-10.53B | 0.00%-10.53B | 0.00%-10.53B | -30.95%-10.53B | ---10.53B |
Shareholders' Equity | -14.21%38.9B | 15.48%45.84B | 4.69%45.34B | -26.89%39.69B | -9.61%43.31B | 9.90%54.29B | 3.34%47.91B | 2.91%49.4B | -5.46%46.37B | -2.53%48B |
Non-controlling interest | -62.40%19.1M | 92.95%71.2M | 1.40%50.8M | 179.55%36.9M | 314.05%50.1M | 186.96%13.2M | -97.85%12.1M | -99.33%4.6M | 249.63%562.2M | 271.55%689.6M |
Total equity | -22.23%43.35B | -4.15%48.01B | 3.44%55.74B | -22.75%50.08B | -7.81%53.89B | 8.17%64.83B | 1.73%58.45B | 1.20%59.93B | 0.37%57.46B | 19.80%59.22B |
Total equity and total liabilities | 0.37%155.08B | 9.56%162.75B | 3.85%154.51B | -5.53%148.55B | -2.49%148.77B | 3.21%157.24B | 1.68%152.57B | 1.81%152.35B | 74.35%150.05B | 94.97%149.64B |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.